What is the cardiac clearance status for a 69-year-old patient with an Revised Cardiac Risk Index (RCRI) of 2, undergoing spinal fusion, with a functional capacity of more than 4 Metabolic Equivalent of Task (METs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiac Clearance for 69-Year-Old Patient with RCRI 2 Undergoing Spinal Fusion

This patient should proceed directly to spinal fusion surgery without further cardiac testing, with perioperative heart rate control using beta-blockade. 1

Algorithmic Assessment

Step 1: Emergency Status

  • This is elective surgery, so proceed with systematic evaluation 1

Step 2: Active Cardiac Conditions

  • No mention of unstable coronary syndrome, decompensated heart failure, severe arrhythmia, or severe valvular disease
  • Proceed to next step 1

Step 3: Surgery Risk Classification

  • Spinal fusion is classified as intermediate-risk surgery (reported cardiac risk 1-5%) 1
  • Not low-risk, so cannot automatically clear based on surgery type alone 1

Step 4: Functional Capacity Assessment (DECISIVE STEP)

  • Patient has >4 METs functional capacity without symptoms 1
  • This is the critical determinant: patients with functional capacity ≥4 METs without symptoms should proceed to planned surgery (Class IIa recommendation, Level of Evidence B) 1
  • In highly functional asymptomatic patients, management rarely changes based on further cardiovascular testing 1

Step 5: Clinical Risk Factors (RCRI = 2)

  • With RCRI of 2, patient has 1-2 clinical risk factors 1
  • However, because functional capacity is ≥4 METs, this overrides the need for testing 1
  • For intermediate-risk surgery with 1-2 risk factors and good functional capacity, proceed with surgery and heart rate control 1

Management Recommendations

Proceed Without Further Testing

  • No preoperative cardiac stress testing is indicated 1
  • Noninvasive testing is only considered for patients with poor functional capacity (<4 METs) and clinical risk factors 1
  • This patient's ability to achieve >4 METs indicates adequate cardiac reserve for the physiologic stress of surgery 1

Perioperative Beta-Blockade

  • Implement perioperative heart rate control with beta-blockade 1
  • This is appropriate for patients with known cardiovascular disease or ≥1 clinical risk factor undergoing intermediate-risk surgery 1

Important Caveats

Spinal Fusion-Specific Considerations

  • The RCRI may underperform in multilevel spine fusion patients due to major transfusion requirements not captured by traditional risk indices 2
  • Despite this limitation, the functional capacity assessment remains the most reliable predictor 3
  • Self-reported ability to climb two flights of stairs (approximating 4 METs) independently predicts cardiac outcomes and improves risk classification beyond RCRI alone 3

What 4 METs Represents

  • Ability to walk 4 blocks or climb 2 flights of stairs 1
  • Patients unable to meet 4-MET demand have increased perioperative and long-term cardiac risk 1
  • This patient exceeds this threshold, indicating low likelihood of perioperative cardiac events 1, 3

Common Pitfall to Avoid

  • Do not order routine preoperative stress testing in patients with adequate functional capacity 4
  • Testing would be Class III (not recommended) in this scenario, as it rarely changes management and delays necessary surgery 1
  • The evidence shows that in patients with ≥4 METs capacity, further cardiovascular testing does not improve outcomes 1

Documentation Requirements

  • Confirm functional capacity assessment is documented (ability to perform specific activities) 1
  • Document RCRI components (the 2 risk factors present) 1
  • Ensure beta-blocker therapy is initiated appropriately perioperatively 1

Related Questions

What is the appropriate wording for cardiac clearance for a 69-year-old male with a functional capacity of more than 4 Metabolic Equivalents (METs) and a Revised Cardiac Risk Index (RCRI) of 2 undergoing spinal fusion surgery?
What is the recommended cardiac risk assessment tool for pre-surgery evaluation?
What risk assessment scores, such as Gupta (Perioperative Cardiac Risk Index) and RCRI (Revised Cardiac Risk Index), should be used for a preoperative workup to evaluate a patient's risk of perioperative cardiac complications?
What are the American Heart Association (AHA) guidelines for predicting myocardial infarction (MI) in patients undergoing non-cardiac surgery?
What preoperative cardiac testing is required for a 66-year-old male with exertional chest pain and no prior cardiac history prior to undergoing lumbar fusion surgery?
Is a recent worsening of OCD symptoms in a patient with a history of obsessive-compulsive disorder (OCD), who has undergone rapid dose changes of Cipramil (citalopram) from 45mg to 52mg to 60mg and back to 52mg, likely due to the dose adjustments or a sign of treatment failure, given that the patient's condition has deteriorated over 7 weeks since the last dose change?
What non-invasive diagnostic tests, aside from echocardiography, can be used to diagnose pulmonary hypertension in patients with varying demographics and medical histories, such as young adults with connective tissue disease or older adults with chronic obstructive pulmonary disease (COPD)?
How does Qelbree (viloxazine) reduce dopamine in patients with attention deficit hyperactivity disorder (ADHD)?
What are the differences between topical and intravenous (IV) administration of Glycyl-Histidyl-Lysine-Copper (GHK-Cu) for skin health and wound healing in patients?
What is the treatment for a patient with iron poisoning in the Intensive Care Unit (ICU)?
Why am I experiencing reduced dopamine levels while taking sertraline (Zoloft) 100mg, Qelbree (viloxazine) 150mg, and guanfacine (Intuniv) 3mg extended release (ER)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.